JPH0692862A - Improver for intestinal flora - Google Patents

Improver for intestinal flora

Info

Publication number
JPH0692862A
JPH0692862A JP4031309A JP3130992A JPH0692862A JP H0692862 A JPH0692862 A JP H0692862A JP 4031309 A JP4031309 A JP 4031309A JP 3130992 A JP3130992 A JP 3130992A JP H0692862 A JPH0692862 A JP H0692862A
Authority
JP
Japan
Prior art keywords
deodorant
culture solution
clostridium butyricum
intestinal
intestinal flora
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4031309A
Other languages
Japanese (ja)
Other versions
JP2998868B2 (en
Inventor
Osamu Otani
治 大谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP4031309A priority Critical patent/JP2998868B2/en
Publication of JPH0692862A publication Critical patent/JPH0692862A/en
Application granted granted Critical
Publication of JP2998868B2 publication Critical patent/JP2998868B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain an improver for intestinal floras capable of eliminating the malodor of a culture solution prepared from Clostridium butyricum or a filtrate thereof and manifesting effects of an active ingredient possessed by the culture solution of the live Clostridium butyricum or the filtrate thereof. CONSTITUTION:This improver for intestinal floras is obtained by blending a culture solution of a live bacterium for controlling the intestinal function represented by Clostridium butyricum with a deodorant and eliminating the malodor of the culture solution or a filtrate thereof. An aqueous extract solution of rice bran is preferred as the deodorant. This improver is an improver for the intestinal floras capable of more manifesting effects of the active ingredient possessed by the culture solution of the Clostridium butyricum or the filtrate thereof and effectively used for humans, livestock, poultries, fisheries animals.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、ヒト、家畜・家禽類、
水産動物に対して投与される腸内菌叢改善剤に関するも
のである。
The present invention relates to humans, livestock and poultry,
The present invention relates to an intestinal flora improving agent administered to aquatic animals.

【0002】[0002]

【従来の技術】従来、クロストリヂウムブチリカムは、
その生菌が整腸剤として有用であることから、例えばヒ
ト、家畜・家禽類、水産動物に用いられている。しかし
ながら、クロストリヂウムブチリカムの生菌は、ヒトに
用いた場合には通常糞便よりの検出率が30%であるこ
と、発育適温が約35℃であること、嫌気性菌であるこ
となどの条件を必要とすることから、ヒト、家畜・家禽
類、水産動物等のいずれの動物の腸内で発育し、その目
的とする整腸等の効果を必ずしも発揮出来ない場合もあ
る。
2. Description of the Related Art Conventionally, Clostridium butyricum has been
Since the live bacterium is useful as an intestinal regulator, it is used for humans, livestock / poultry, and aquatic animals. However, when Clostridium butyricum is used as a live bacterium, the detection rate from normal faeces is 30% when used in humans, the optimum growth temperature is approximately 35 ° C, and it is an anaerobic bacterium. Since the above conditions are required, there are cases in which the animal grows in the intestine of any animal such as humans, livestock / poultry, and aquatic animals, and the desired effects such as intestinal regulation are not always exhibited.

【0003】一方、整腸を目的とするクロストリヂウム
ブチリカムの生菌からなる整腸生菌剤は、安全性を有す
ることから、腸内菌叢の異常により発生する諸症状の改
善、家畜・家禽類や水産動物の増体、飼料効率の向上を
目的として用いられており、近年の安全性指向からも、
より有効なクロストリヂウムブチリカムの生菌の改良が
期待されている。
On the other hand, since the intestinal bioactive agent composed of live bacteria of Clostridium butyricum for the purpose of intestinal regulation has safety, it improves the various symptoms caused by abnormal intestinal flora, It is used for the purpose of increasing the weight of livestock, poultry and aquatic animals, and improving feed efficiency.
It is expected that more effective live bacteria of Clostridium butyricum will be improved.

【0004】[0004]

【発明が解決しようとする課題】上記の様に、クロスト
リヂウムブチリカムの生菌は整腸剤、ならびに飼料に混
合して用いられ、ヒト、家畜・家禽、水産動物にとって
有害な菌に制御的に働き、また有用な菌には促進的に働
き腸内菌叢を改善するとされている。
As described above, the live bacteria of Clostridium butyricum are used as an intestinal regulating agent and mixed with feed, and are controllable to bacteria harmful to humans, livestock / poultry and aquatic animals. It is also said that it works to promote useful bacteria and improves intestinal flora.

【0005】このクロストリヂウムブチリカムの生菌
は、芽胞を有する嫌気性菌であり、0.5%ブドウ糖加
普通寒天培地で37℃、48時間培養し、その培養液を
顕微鏡で観察すると、ほとんど直線状か、まれにやや弯
曲した桿菌であり、卵形の芽胞を形成している。また、
その培養液中には、生菌の他に、代謝産物である酪酸,
酢酸等の有機酸、および自己融解した菌体成分が含有さ
れている。
The live bacterium of Clostridium butyricum is an anaerobic spore-bearing bacterium, which is cultured in a normal agar medium containing 0.5% glucose at 37 ° C. for 48 hours, and the culture solution is observed under a microscope. , An almost linear or rarely slightly curved bacillus, forming oval-shaped spores. Also,
In the culture solution, in addition to live bacteria, butyric acid, which is a metabolite,
It contains organic acids such as acetic acid, and autolyzed cell components.

【0006】しかしながら、クロストリヂウムブチリカ
ムの培養液をろ過して、生菌を回収した後に残る培養ろ
液には、上述のごとく、有機酸や自己融解した菌体成分
を含有しており、ヒト、家畜・家禽、水産動物にとって
有効であるが、特に有機酸として酪酸を含有しているた
めに、悪臭を有する欠点がある。例えば、酪酸の臭いの
閾値(臭いの種類を判別することのできる限界濃度)
は、ベッセイ(Bessay)によれば、4.3×10
13(分子数/cc)であることからわかるように、ヒト
が忌避する臭いの一つである。そのために、クロストリ
ヂウムブチリカムの培養液あるいは培養ろ液は、そのま
までは飲用し難く、また家畜・家禽、水産動物に投与す
るとき、その臭いが作業者とって不快であることから、
その有効利用は未だ考慮されず、クロストリヂウムブチ
リカムの培養液から分離した生菌のみが利用されてい
た。
However, as described above, the culture filtrate remaining after the filtration of the culture solution of Clostridium butyricum to recover the viable cells contains the organic acid and the autolyzed cell components. It is effective for humans, livestock / poultry, and aquatic animals, but has a drawback of having a bad odor because it contains butyric acid as an organic acid. For example, butyric acid odor threshold (limit concentration that can distinguish the type of odor)
Is 4.3 × 10 according to Bessay
As can be seen from the fact that it is 13 (number of molecules / cc), it is one of the odors that humans avoid. Therefore, the culture solution or culture filtrate of Clostridium butyricum is difficult to drink as it is, and when administered to livestock, poultry, and aquatic animals, its odor is unpleasant for workers,
The effective utilization was not considered yet, and only the viable bacteria isolated from the culture solution of Clostridium butyricum were used.

【0007】本発明は、この様な従来技術の欠点を改善
するためになされたものであり、クロストリヂウムブチ
リカムの生菌の培養液あるいは培養ろ液の悪臭を消臭
し、クロストリヂウムブチリカムの生菌の培養液あるい
は培養ろ液が有する有効成分の効果をより発揮させた、
ヒト、家畜・家禽類、水産動物に対して有効な腸内菌叢
改善剤を提供することを目的とするものである。
The present invention has been made in order to improve the above-mentioned drawbacks of the prior art, and eliminates the bad odor of the culture broth or the culture filtrate of the live bacterium of Clostridium butyricum and eliminates the odor. The effect of the active ingredient contained in the culture solution or the culture filtrate of live bacterium of D. butyricum was exhibited more effectively.
It is intended to provide an effective intestinal flora improving agent for humans, livestock / poultry, and aquatic animals.

【0008】[0008]

【課題を解決するための手段】すなわち、本発明は、ク
ロストリヂウムブチリカムを代表とする整腸生菌の培養
ろ液に消臭剤を配合した消臭培養ろ液を有効成分として
含有することを特徴とする腸内菌叢改善剤である。
Means for Solving the Problems That is, the present invention contains, as an active ingredient, a deodorant culture filtrate in which a deodorant is added to a culture filtrate of a viable intestinal bacterium represented by Clostridium butyricum. It is an intestinal flora improving agent characterized by being

【0009】また、本発明は、クロストリヂウムブチリ
カムを代表とする整腸生菌の培養液に消臭剤を配合した
消臭培養液を有効成分として含有することを特徴とする
腸内菌叢改善剤である。
Further, the present invention is characterized in that the deodorant culture solution containing a deodorant in a culture solution of live intestinal bacterium represented by Clostridium butyricum is contained as an active ingredient. It is a flora improving agent.

【0010】以下、本発明を詳細に説明する。本発明の
腸内菌叢改善剤は、クロストリヂウムブチリカムを代表
とする整腸生菌の培養液、またはクロストリヂウムブチ
リカムを代表とする整腸生菌の培養ろ液に消臭剤を配合
して無臭化してなる、消臭培養液または消臭培養ろ液を
有効成分として含有するものである。
The present invention will be described in detail below. The intestinal flora improving agent of the present invention is dissolved in a culture solution of live intestinal bacteria represented by Clostridium butyricum or a culture filtrate of live intestine bacteria represented by Clostridium butyricum. It contains a deodorant culture solution or a deodorant culture filtrate, which is deodorized by adding an odorant, as an active ingredient.

【0011】本発明においては、消臭剤としては、例え
ば米糠の水抽出液、サイクロデキストリンのような感覚
的消臭剤、活性炭のような物理的消臭剤等の消臭剤が用
いられるが、それらの中でも特に米糠の水抽出液が好ま
しい。消臭剤の添加量は、クロストリヂウムブチリカム
の培養液または培養ろ液100重量部に対して1〜30
重量部、好ましくは5〜20重量部が望ましい。1重量
部未満では消臭が十分に行なわれず、30重量部を越え
て用いても消臭効果は変わらず、かえって消臭剤の量が
多くなり、培養液あるいは培養ろ液が有する有効成分の
効果を減少させる。ただし、上記の消臭剤の添加量の中
の米糠の水抽出液の添加量は、無水物としての添加量を
示す。
In the present invention, as the deodorant, for example, a water extract of rice bran, a sensory deodorant such as cyclodextrin, and a physical deodorant such as activated carbon are used. Of these, a water extract of rice bran is particularly preferable. The amount of the deodorant added is 1 to 30 with respect to 100 parts by weight of the culture solution or culture filtrate of Clostridium butyricum.
Parts by weight, preferably 5 to 20 parts by weight are desirable. If it is less than 1 part by weight, deodorization is not sufficiently performed, and even if it is used in excess of 30 parts by weight, the deodorizing effect does not change, and the amount of the deodorant increases, and the amount of the active ingredient contained in the culture solution or culture filtrate is increased. Diminishes the effect. However, the addition amount of the water extract of rice bran in the addition amount of the above deodorant indicates the addition amount as an anhydride.

【0012】消臭剤として米糠の水抽出液を用いた具体
例を示すと、クロストリヂウムブチリカムを0.5%ブ
ドウ糖加普通ブイヨン培地で37℃、48時間培養して
得た培養ろ液100重量部に、例えば消臭剤として表1
に示す成分からなる米糖の水抽出液を5〜40重量部、
好ましくは10〜20重量部、さらに好ましくは12重
量部程度を加えることにより、消臭の目的を達成するこ
とができる。なお、使用する培地は0.5%ブドウ糖加
普通寒天培地に限らず、例えば牛乳のごときクロストリ
ヂウムブチリカムが発育する培地であれば良い。
A specific example of using a rice bran water extract as a deodorant is as follows: Clostridium butyricum was cultured in a normal broth medium containing 0.5% glucose at 37 ° C. for 48 hours to obtain a culture filter. To 100 parts by weight of the liquid, for example, as a deodorant, Table 1
5 to 40 parts by weight of an aqueous extract of rice sugar comprising the components shown in
The purpose of deodorization can be achieved by adding preferably 10 to 20 parts by weight, and more preferably about 12 parts by weight. The medium to be used is not limited to the normal agar medium supplemented with 0.5% glucose, but may be any medium such as milk that allows growth of Clostridium butyricum.

【0013】[0013]

【表1】 [Table 1]

【0014】クロストリヂウムブチリカムの整腸生菌の
消臭培養ろ液または生菌を含む消臭培養液からなる腸内
菌叢改善剤は、通常ヒト、家畜・家禽および水産動物に
対し、体重1kg当たり1日0.1ml〜10ml、好
ましくは1ml〜4ml投与するのが望ましい。
An intestinal flora improving agent consisting of a deodorant culture filtrate of an intestinal live bacterium of Clostridium butyricum or a deodorant culture broth containing a viable bacterium is usually used for humans, livestock / poultry and aquatic animals. It is desirable to administer 0.1 ml to 10 ml, preferably 1 ml to 4 ml per 1 kg of body weight per day.

【0015】また、クロストリヂウムブチリカムの生菌
の消臭培養ろ液または生菌を含む消臭培養液からなる腸
内菌叢改善剤は、液状のまま投与してもよく、または担
体と混合して投与してもよい。担体としては乳糖、澱粉
などが用いられ、散剤、顆粒剤、錠剤の形態で投与して
もよい。
The intestinal flora improving agent comprising a deodorant culture filtrate of a live bacterium of Clostridium butyricum or a deodorant culture containing a live bacterium may be administered as a liquid, or may be a carrier. It may be administered as a mixture with. Lactose, starch and the like are used as carriers, and they may be administered in the form of powder, granules or tablets.

【0016】[0016]

【実施例】以下、実施例を示し、本発明をさらに具体的
に説明する。ただし、本発明はこれらの実施例に限定さ
れるものではない。
EXAMPLES The present invention will be described more specifically below with reference to examples. However, the present invention is not limited to these examples.

【0017】実施例1 ヒト、家畜・家禽、水産動物にとって有害な菌に対する
抑制作用。 使用菌株 エシリシア コリー(Escherichia col
i)、サルモネラ エンテリティディス(Salmon
ella enteritidis)、カンディダ ア
ルビカンス(Candida albicans)、ク
ロストリヂウムパラプトリフィカム(Clostrid
ium Paraputrificam)。 使用培地 0.5%ブドウ糖加普ブイヨン寒天培地。
Example 1 Inhibitory action against bacteria harmful to humans, livestock / poultry and aquatic animals. Used strain Escherichia col
i), Salmonella Enteritidis
ella enteritidis), Candida albicans, Clostridium paraptophyticum (Clostrid)
ium Paraputrificam). Use medium 0.5% glucose-added broth agar medium.

【0018】培養方法 エシリシア コリー(Escherichia col
i)、サルモネラ エンテリティディス(Salmon
ella enteritidis)、カンディダ ア
ルビカンス(Candida albicans)につ
いては、37℃,24時間好気培養、クロストリヂウム
パラプトリフィカム(Clostridium Pa
raputrificam)は37℃,48時間嫌気培
養。
Culture Method Escherichia col
i), Salmonella Enteritidis
ella enteritidis) and Candida albicans, aerobically cultivated at 37 ° C. for 24 hours, Clostridium palptophycum (Clostridium Pa)
rapeuticam) was anaerobically cultured at 37 ° C for 48 hours.

【0019】試験物質 A剤 本発明の方法によるもの。即ち、クロストリヂウムブチ
リカムの0.5%ブドウ糖加普通ブイヨン培地の37
℃,48時間培養した培養ろ液100重量部に、消臭剤
として表1に示す成分の米糖の水抽出液を12重量部を
加えたもの。消臭剤を添加した後の培養ろ液の臭はなか
った。 B剤 従来の整腸剤として用いられる方法によるもの。即ち、
クロストリヂウムブチリカムの0.5%ブドウ糖加普通
ブイヨン培地の37℃,48時間培養した培養液を遠心
分離して得た生菌を凍結乾燥したもの。
Test substance Agent A According to the method of the present invention. That is, 37% of normal broth medium containing 0.5% glucose of Clostridium butyricum
12 parts by weight of a water extract of rice sugar having the components shown in Table 1 as a deodorant was added to 100 parts by weight of a culture filtrate which was cultured at 48 ° C. for 48 hours. There was no odor in the culture filtrate after adding the deodorant. Agent B By the method used as a conventional intestinal regulating agent. That is,
A freeze-dried live bacterium obtained by centrifuging a culture solution obtained by culturing Clostridium butyricum in a normal broth medium containing 0.5% glucose at 37 ° C for 48 hours.

【0020】抑制作用測定法 使用菌株を0.5%ブドウ糖加普通ブイヨン培地で24
時間培養した液0.1mlを、使用培地に滴下し一面に
広げた後、ペニシリン検定カップをおき、A剤及びB剤
をペニシリン検定カップに加え、それぞれの菌の培養方
法で培養し、ペニシリン検定カップの縁より生じた使用
菌株の発育阻止帯の幅を測定した。
Assay method for inhibitory effect The strains used were 24 in normal broth medium containing 0.5% glucose.
After 0.1 ml of the time-cultured solution was added dropwise to the medium used and spread over one side, a penicillin assay cup was placed, agents A and B were added to the penicillin assay cup, and the cells were cultured according to the culture method for each bacterium, and the penicillin assay was performed. The width of the growth inhibition zone of the strain used, which was generated from the edge of the cup, was measured.

【0021】測定結果 表2に示すとおり、本発明のA剤は使用菌株が好気性菌
であるエシリシア コリー(Escherichia
coli)、サルモネラ エンテリティディス(Sal
monella enteritidis)、カンディ
ダ アルビカンス(Candida albican
s)、並びに嫌気性菌であるクロストリヂウム パラプ
トリフィカム(Clostridium Parapu
trificam)に対し発育抑制作用を有したが、従
来のB剤は好気性菌に対しては発育阻止作用を示さず、
嫌気性菌に対してのみ発育阻止作用を示した。
Measurement Results As shown in Table 2, the agent A of the present invention was used in Escherichia coli whose strain is aerobic.
coli), Salmonella enteritidis (Sal
monella enteritidis, Candida albican
s) as well as the anaerobic bacterium Clostridium Parapupu
However, the conventional agent B does not show a growth inhibitory effect on aerobic bacteria,
It showed a growth inhibitory effect only on anaerobic bacteria.

【0022】[0022]

【表2】 (注) +:発育阻止幅が3mm以上 −:発育阻止幅がみられず[Table 2] (Note) +: Growth inhibition width is 3 mm or more-: Growth inhibition width is not seen

【0023】表2に示す結果は、腸内の状態をそのまま
表すものではないが、腸内が好気的な場合、クロストリ
ヂウムブチリカムの生菌は嫌気性菌のため発育出来ず、
ヒト、家畜・家禽、水産動物にとって有害な好気性菌を
制御出来ない場合もあることを示すのに対し、本発明の
腸内菌叢改善剤は、ヒト、家畜・家禽、水産動物にとっ
て有害な好気性菌及び嫌気性菌の両方に作用を示すこと
が認められる。
The results shown in Table 2 do not represent the state of the intestine as it is, but when the intestine is aerobic, viable bacteria of Clostridium butyricum cannot grow because they are anaerobic bacteria.
While showing that aerobic bacteria harmful to humans, livestock / poultry and aquatic animals may not be controlled in some cases, the intestinal flora improving agent of the present invention is harmful to humans, livestock / poultry and aquatic animals. It is observed to act on both aerobic and anaerobic bacteria.

【0024】実施例2 ブロイラーに対する効果 本発明の腸内菌叢改善剤のブロイラーに対する投与効果
を確認するための野外応用試験を実施した。
Example 2 Effect on broiler A field application test was conducted to confirm the effect of administration of the intestinal flora improving agent of the present invention on broiler.

【0025】実施方法 使用管理はウインドレス、平飼いで床面を給温した。試
験区分はA剤投与区、B剤投与区とし、市販飼料にA剤
を0.1重量%、B剤を0.1重量%添加した。なお、
B剤は添加に当たって生菌数を測定し、常時一定菌数に
なるよう管理した。使用したブロイラーはA剤投与区、
B剤投与区とも2,000羽とした。
Method of Use The floor was warmed in a windless, flat-bed house for use management. The test categories were the A agent administration group and the B agent administration group, in which 0.1% by weight of A agent and 0.1% by weight of B agent were added to the commercial feed. In addition,
For the agent B, the viable cell count was measured upon addition, and the cell count was controlled so that it would always remain constant. The broiler used was the A agent administration group,
2,000 birds were administered to each of the B agent administration groups.

【0026】実施結果Implementation result

【0027】[0027]

【表3】 [Table 3]

【0028】表3に示す結果から、本発明の腸内菌叢改
善剤は、従来のものに比べ、出荷羽数、飼料要求率を改
善する傾向にあった。また、作業者より、臭いなどの扱
いにくさに対する苦情はなかった。
From the results shown in Table 3, the intestinal flora improving agent of the present invention tended to improve the number of shipped birds and the feed requirement rate as compared with the conventional agents. In addition, there were no complaints from workers regarding the difficulty of handling odors.

【0029】実施例3 実施例1,2において、A剤の代わりに、クロストリヂ
ウムブチリカムの0.5%ブドウ糖加普通ブイヨン培地
の37℃,48時間培養した培養液100重量部に、消
臭剤として表1に示す成分の米糖の水抽出液を12重量
部を加えたものを用いた以外は、実施例1,2と同様の
試験を行なった。培養液の臭は消臭され、また実施例
1,2と同様の結果が得られた。
Example 3 In Examples 1 and 2, 100 parts by weight of a culture solution obtained by culturing 48 hours at 37 ° C. in a normal broth medium containing 0.5% glucose of Clostridium butyricum was used in place of the agent A. The same tests as in Examples 1 and 2 were performed, except that 12 parts by weight of a water extract of rice sugar having the components shown in Table 1 was used as the deodorant. The odor of the culture solution was deodorized, and the same results as in Examples 1 and 2 were obtained.

【0030】[0030]

【発明の効果】以上説明した様に、本発明によれば、ク
ロストリヂウムブチリカムの生菌の培養液あるいは培養
ろ液の有する悪臭は消臭され、クロストリヂウムブチリ
カムの生菌の培養液あるいは培養ろ液が有する有効成分
の効果を発揮させることができ、ヒト、家畜・家禽類、
水産動物に対して有効な腸内菌叢改善剤を提供すること
ができる。
As described above, according to the present invention, the bad odor of the culture solution or the culture filtrate of the viable bacteria of Clostridium butyricum is eliminated, and the viable bacteria of Clostridium butyricum is eliminated. It is possible to exert the effect of the active ingredient contained in the culture solution or culture filtrate of, human, livestock / poultry,
It is possible to provide an effective intestinal flora improving agent for aquatic animals.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 クロストリヂウムブチリカムを代表とす
る整腸生菌の培養ろ液に消臭剤を配合した消臭培養ろ液
を有効成分として含有することを特徴とする腸内菌叢改
善剤。
1. An intestinal flora containing, as an active ingredient, a deodorant culture filtrate in which a deodorant is mixed with a culture filtrate of a living intestinal bacterium represented by Clostridium butyricum. Improver.
【請求項2】 クロストリヂウムブチリカムを代表とす
る整腸生菌の培養液に消臭剤を配合した消臭培養液を有
効成分として含有することを特徴とする腸内菌叢改善
剤。
2. An intestinal flora improving agent, which contains as an active ingredient a deodorant culture solution prepared by mixing a deodorant into a culture solution of a living intestinal bacterium represented by Clostridium butyricum. .
【請求項3】 消臭剤が米糠の水抽出液である請求項1
または2記載の腸内菌叢改善剤。
3. The deodorant is a water extract of rice bran.
Alternatively, the intestinal flora improving agent described in 2.
【請求項4】 ヒトに対して投与されるものである請求
項1または2記載の腸内菌叢改善剤。
4. The intestinal flora improving agent according to claim 1 or 2, which is administered to humans.
【請求項5】 家畜・家禽または水産動物に投与される
ものである請求項1または2記載の腸内菌叢改善剤。
5. The intestinal flora improving agent according to claim 1, which is administered to livestock, poultry or aquatic animals.
【請求項6】 請求項1または2記載の消臭培養ろ液ま
たは消臭培養液を担体と混合してなる腸内菌叢改善剤。
6. An intestinal flora improving agent obtained by mixing the deodorant culture filtrate or deodorant culture solution according to claim 1 or 2 with a carrier.
JP4031309A 1992-01-23 1992-01-23 Intestinal flora improver Expired - Fee Related JP2998868B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4031309A JP2998868B2 (en) 1992-01-23 1992-01-23 Intestinal flora improver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4031309A JP2998868B2 (en) 1992-01-23 1992-01-23 Intestinal flora improver

Publications (2)

Publication Number Publication Date
JPH0692862A true JPH0692862A (en) 1994-04-05
JP2998868B2 JP2998868B2 (en) 2000-01-17

Family

ID=12327691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4031309A Expired - Fee Related JP2998868B2 (en) 1992-01-23 1992-01-23 Intestinal flora improver

Country Status (1)

Country Link
JP (1) JP2998868B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022758A1 (en) 1996-11-15 1998-05-28 Matsushita Refrigeration Company Damper device and method for driving the same
JP2007031291A (en) * 2005-07-22 2007-02-08 Ace Bio Product Kk Body weight increase-inhibiting agent and body weight increase-inhibiting drink
US20140342438A1 (en) * 2011-09-14 2014-11-20 University Of Guelph Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
WO2015119170A1 (en) * 2014-02-07 2015-08-13 ミヤリサン製薬株式会社 Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022758A1 (en) 1996-11-15 1998-05-28 Matsushita Refrigeration Company Damper device and method for driving the same
JP2007031291A (en) * 2005-07-22 2007-02-08 Ace Bio Product Kk Body weight increase-inhibiting agent and body weight increase-inhibiting drink
US20140342438A1 (en) * 2011-09-14 2014-11-20 University Of Guelph Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
US11045505B2 (en) 2011-09-14 2021-06-29 Nubiyota Llc Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
WO2015119170A1 (en) * 2014-02-07 2015-08-13 ミヤリサン製薬株式会社 Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium
JP6076509B2 (en) * 2014-02-07 2017-02-08 ミヤリサン製薬株式会社 Peptide having activity to suppress toxin production of Clostridium bacteria
US10214561B2 (en) 2014-02-07 2019-02-26 Miyarisan Pharmaceutical Co., Ltd. Peptide having activity of inhibiting production of toxin by bacterium belonging to genus clostridium

Also Published As

Publication number Publication date
JP2998868B2 (en) 2000-01-17

Similar Documents

Publication Publication Date Title
JP2879321B2 (en) Oral composition for animals
EP0720974B1 (en) Bacterial preparation and its use for treating wastes of biological origin
US5667779A (en) Fungal inhibiting composition comprising Bacillus subtilis FERM BP-3418
JPH08298982A (en) Complex microbial pharmaceutical preparation
JP2009057284A (en) Microbial preparation for reducing greenhouse effect gas excreted from livestock or fowl
JPH10330274A (en) Administration of live bacterial agent for birds
JPH08502019A (en) Probiotech for Salmonella control
US11680003B2 (en) Treatment of animal and poultry waste to reduce odor
Lyons Probiotics: an alternative to antibiotics.
JP2005245299A (en) New lactic acid bacterium
JPH0692862A (en) Improver for intestinal flora
JP2011193858A (en) γ-AMINOBUTYRIC ACID-CONTAINING FEED, METHOD FOR PRODUCING THE SAME, AND METHOD FOR RAISING LIVESTOCK USING THE FEED
JP6864293B2 (en) Foul odor reduction method
JP2005130820A (en) Viable microbe agent containing thermophile bacteria
JP3180886B2 (en) Animal growth promoter
KR0141019B1 (en) A process of rearing chickens
JP3834460B2 (en) Animal teat sanitizer
JP2007117004A (en) Animal feed additive containing bile acid tolerance bacterium
JPH05192087A (en) Fermented healthy feed
KR102324295B1 (en) Eco-friendly livestock floor treatment composition and its manufacturing method
Walton et al. A possible mechanism to explain the growth promotion effect of feed antibiotics in farm animals: zinc bacitracin induced cell wall damage in Escherichia coli in vitro
CN109717139A (en) The nonreactive cultivation method of pig
WO2018029595A1 (en) Probiotic preparation, method of its preparation and use of probiotic preparation
JP3009203B2 (en) Campylobacter Growth Inhibitors in Poultry or Livestock
CN106811437B (en) Complex microbial inoculant and application thereof

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees